help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bevilacqua, M. P.
Right arrow Articles by Gimbrone, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bevilacqua, M. P.
Right arrow Articles by Gimbrone, M. A., Jr

American Journal of Pathology, Vol 121, 394-403, Copyright © 1985 by American Society for Investigative Pathology


REGULAR ARTICLES

Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion

MP Bevilacqua, JS Pober, ME Wheeler, RS Cotran and MA Gimbrone Jr

Interleukin-1 (IL-1), an inflammatory/immune mediator, acts directly and selectively on cultured human vascular endothelial cells to alter two important functional properties. First, IL-1 induces endothelial cell biosynthesis and surface expression of a tissue factor-like procoagulant activity. Second, IL-1 dramatically increases the adhesiveness of the endothelial cell surface for human peripheral blood polymorphonuclear leukocytes (6-42-fold increase) and monocytes (2-5- fold increase), as well as the related leukocyte cell lines HL-60 and U937. These IL-1 effects are concentration-dependent (maximum, 5-10 U/ml), time-dependent (peak 4-6 hours), and reversible. Cycloheximide and actinomycin D block these IL-1 actions on endothelium, which suggests the requirement for de novo protein synthesis. Human-monocyte- derived IL-1, cell-line--derived IL-1, and recombinant IL-1 exhibited comparable biologic activities in our assays, whereas two other mediators, IL-2 and immune interferon, were without effect. IL-1 stimulated procoagulant activity and leukocyte adhesion in human endothelial cells cultured from both umbilical veins and adult saphenous veins but not in other cultured cell types, including SV-40- transformed human endothelial cells and human dermal fibroblasts. Similar actions of IL-1 on vascular endothelium in vivo may contribute to the development of intravascular coagulation and enhanced leukocyte-- vessel wall adhesion at sites of inflammation.


This article has been cited by other articles:


Home page
Circ. Res.Home page
G. J. Brunn, S. Saadi, and J. L. Platt
Differential Regulation of Endothelial Cell Activation by Complement and Interleukin 1{alpha}
Circ. Res., March 31, 2006; 98(6): 793 - 800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-Q. Wu and W. C. Aird
Thrombin, TNF-{alpha}, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H873 - H885.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Merhi-Soussi, B. R. Kwak, D. Magne, C. Chadjichristos, M. Berti, G. Pelli, R. W. James, F. Mach, and C. Gabay
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice
Cardiovasc Res, June 1, 2005; 66(3): 583 - 593.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Isoda, S. Sawada, N. Ishigami, T. Matsuki, K. Miyazaki, M. Kusuhara, Y. Iwakura, and F. Ohsuzu
Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1068 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kobayashi, N. Inoue, Y. Ohashi, M. Terashima, K. Matsui, T. Mori, H. Fujita, K. Awano, K. Kobayashi, H. Azumi, et al.
Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque Instability: Important Role of C-Reactive Protein
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1398 - 1404.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, J. Adams, P. J. Elliott, and M. Chopp
Postischemic (6-Hour) Treatment With Recombinant Human Tissue Plasminogen Activator and Proteasome Inhibitor PS-519 Reduces Infarction in a Rat Model of Embolic Focal Cerebral Ischemia
Stroke, December 1, 2001; 32(12): 2926 - 2931.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Zhu, H. Liao, N. Wang, K.-S. Ma, L. K. Verna, J. Y.-J. Shyy, S. Chien, and M. B. Stemerman
LDL-Activated p38 in Endothelial Cells Is Mediated by Ras
Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1159 - 1164.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H.-Y. Lee, M. E. Kehrli Jr., K. A. Brogden, J. M. Gallup, and M. R. Ackermann
Influence of beta 2-Integrin Adhesion Molecule Expression and Pulmonary Infection with Pasteurella haemolytica on Cytokine Gene Expression in Cattle
Infect. Immun., July 1, 2000; 68(7): 4274 - 4281.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. M. Boyle Jr, S. T. Lille, E. Allaire, A. W. Clowes, and E. D. Verrier
Endothelial Cell Injury in Cardiovascular Surgery: Atherosclerosis
Ann. Thorac. Surg., March 1, 1997; 63(3): 885 - 894.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. D. Verrier and E. M. Boyle Jr
Endothelial Cell Injury in Cardiovascular Surgery
Ann. Thorac. Surg., September 1, 1996; 62(3): 915 - 922.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Society for Investigative Pathology.